Prosecution Insights
Last updated: October 02, 2026

Regents of the University of Minnesota

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

83 pending office actions • 45 art units • 81 examiners • 0 of 83 (0%) have an AI response strategy ready • 74 patents granted in the last 365 days

Analysis

The Regents of the University of Minnesota currently manage 79 pending office actions within the Biotechnology & Pharmaceuticals technology area. This portfolio is notable for its level of dispersion, as the actions are spread across 46 distinct art units. This suggests a broad research and patenting scope that touches many different specialized groups at the USPTO. The prosecution involves 77 distinct examiners, which means that the workload is highly distributed across the various individuals.

PATEL, RONAK C is the busiest examiner for the university, currently overseeing 2 pending office actions. Given that there are 79 total pending actions and 77 distinct examiners, the vast majority of examiners are only handling a single application. This distribution requires the university to navigate 46 different art unit environments and 77 individual examiner perspectives simultaneously, with very little opportunity for consolidated negotiation or examiner-specific precedent within the active portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

83
Total Pending OAs
60
Non-Final OAs
19
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 26 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

11
Overdue
1
Due this week
8
Due this month
5
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 26 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (11)Due ≤ 7 days (1)Due ≤ 30 days (8)Due ≤ 60 days (5)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

50
Hard (60%)
27
Medium (33%)
6
Easy (7%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other10 (12%)
§103 only20 (24%)
§102 only1 (1%)
§112 only4 (5%)
Double-patenting only2 (2%)
Double-patenting + other6 (7%)
Multi-statute (no §101)40 (48%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

37
Life Sciences
45% of docket
2
Information Tech
2% of docket
0
Communications
0% of docket
4
Semiconductors
5% of docket
19
Mechanical / Eng
23% of docket
21
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

830 h
Manual time on pending OAs
166 h
Time saved (low, 20%)
290 h
Time saved (mid, 35%)
7.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PATEL, RONAK C 2 51.2% +56.4%
BELYAVSKYI, MICHAIL A 2 64.2% +27.6%
SHEN, YANXIN NMN 1 90.0% +22.5%
YANG, YI-SHAN 1 70.6% +53.3%
STANLEY, TYLER JAY 1 46.9% +54.2%
NUR, ABDULLAHI 1 88.2% +6.1%
NGANGA, BONIFACE N 1 64.2% +28.8%
PATEL, TULSIDAS C 1 42.6% +21.2%
ARIANI, KADE 1 74.9% +32.4%
MOLOYE, TITILAYO 1 62.5% +47.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19228322 HYPERSPECTRAL IMAGING FOR EARLY DETECTION OF ALZHEIMER'S DISEASE NUR, ABDULLAHI —

Hard Cases (50)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18109039 Cardiopulmonary Resuscitation Catheter and Related Systems and Methods GRAY, PHILLIP A 126d overdue
18501663 DEVICE FOR TREATMENT OF TRAUMATIC BRAIN INJURY AND RELATED SYSTEMS AND METHODS SIRCAR, ALISHA JITENDRA 98d overdue
18000258 COPOLYMERS FOR INTRACELLULAR THERAPEUTIC NUCLEIC ACID PAYLOAD DELIVERY SASTRI, SATYA B 66d overdue
18337578 LOCAL VOLT/VAR CONTROLLERS WITH STABILITY GUARANTEES YOON, ERIC 5d overdue
18639608 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF MCDOWELL, BRIAN E 3d overdue
19041455 WIND-DRIVEN ENERGY APPARATUSES AND METHODS THEREOF PATEL, TULSIDAS C 2d overdue
17953981 NON-FIBRILLAR HEMOGLOBIN S OLIGOMERS AND METHODS TO IDENTIFY MODULATORS OF HEMOGLOBIN S POLYMERIZATION TURK, NEIL N 8d
18237360 METALLOENZYME MODULATORS PIHONAK, SARAH 27d

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19041455 WIND-DRIVEN ENERGY APPARATUSES AND METHODS THEREOF PATEL, TULSIDAS C 2d overdue
19326385 ENGINEERED GENETIC INCOMPATIBILITY IN PLANTS SHEN, YANXIN NMN —
19153797 MULTIMODAL ULTRASOUND AND ACOUSTIC SYSTEM AND METHOD FOR NOVEL NON-INVASIVE HEARING ASSESSMENT AND INTRACRANIAL PRESSURE MONITORING YANG, YI-SHAN —
19236658 Multi-Speed Ergonomic Wheelchair And Devices And Methods Therefor STANLEY, TYLER JAY —
19202430 REVERSIBLE THERMAL NEUROMODULATION USING FOCUSED ULTRASOUND NGANGA, BONIFACE N —
18961073 COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT ARIANI, KADE —
18916866 SILICA-COATED STIMULUS-RESPONSIVE POLYMERIC NANOPARTICLES PATEL, RONAK C —
18915826 METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN MOLOYE, TITILAYO —

Top Art Units

Art UnitApps
3783 4
1632 3
1663 2
2896 2
1624 2
3796 2
1653 2
1796 2
1641 2
1797 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19326385 ENGINEERED GENETIC INCOMPATIBILITY IN PLANTS SHEN, YANXIN NMN 1663 §102§103§112 Non-Final OA — Pending Sep 11, 2025
19153797 MULTIMODAL ULTRASOUND AND ACOUSTIC SYSTEM AND METHOD FOR NOVEL NON-INVASIVE HEARING ASSESSMENT AND INTRACRANIAL PRESSURE MONITORING YANG, YI-SHAN 3798 §101§102§103§112 Non-Final OA — Pending Aug 05, 2025
19236658 Multi-Speed Ergonomic Wheelchair And Devices And Methods Therefor STANLEY, TYLER JAY 3611 §102§103§112 Non-Final OA — Pending Jun 12, 2025
19228322 HYPERSPECTRAL IMAGING FOR EARLY DETECTION OF ALZHEIMER'S DISEASE NUR, ABDULLAHI — §103Other Non-Final OA — Pending Jun 04, 2025
19202430 REVERSIBLE THERMAL NEUROMODULATION USING FOCUSED ULTRASOUND NGANGA, BONIFACE N 3797 §101§102§103§112 Non-Final OA — Pending May 08, 2025
19041455 WIND-DRIVEN ENERGY APPARATUSES AND METHODS THEREOF PATEL, TULSIDAS C 2896 §102§103 Non-Final OA 2d overdue Pending Jan 30, 2025
18961073 COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT ARIANI, KADE — §103§112DP Non-Final OA — Pending Nov 26, 2024
18916866 SILICA-COATED STIMULUS-RESPONSIVE POLYMERIC NANOPARTICLES PATEL, RONAK C — §103 Non-Final OA — Pending Oct 16, 2024
18915826 METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN MOLOYE, TITILAYO — DP Non-Final OA — Pending Oct 15, 2024
18846873 THERAPEUTIC COMPOUND AND SALTS ABDALHAMEED, MANAHIL MIRGHANI ALI — §102§103§112 Non-Final OA — Pending Sep 13, 2024
18818917 MOTOR UNIT CHIP, MANUFACTURING METHOD THEREOF AND METHOD OF DETECTING PATHOLOGICAL EVENT USING THE SAME KELLY, ROBERT M — §102§112 Non-Final OA — Pending Aug 29, 2024
18832026 ANTI-B7-H3 COMPOUNDS AND METHODS OF USE LIPPERT, JOHN WILLIAM — §102§103 Non-Final OA — Pending Jul 22, 2024
18726717 HEMOSTATIC COMPOSITION CONTAINING RECOMBINANT HUMAN CLOTTING FACTORS, AND METHOD OF PRODUCING RAMIREZ, DELIA M — §112 Non-Final OA — Pending Jul 03, 2024
18667481 SYSTEMS AND METHODS FOR TREATING STORMWATER WITH ANAMMOX BACTERIA VARMA, AKASH K — §103§112 Non-Final OA — Pending May 17, 2024
18708411 COMPOSITIONS AND METHODS FOR TRANSCRIPTIONAL ACTIVATION STEPHENS, REBECCA JOHANNA 1663 §103§112DP Non-Final OA — Pending May 08, 2024
18654961 VIRAL ANTIGEN DISPLAY COMPOSITIONS AND METHODS CORNELIUS, CLAIRE ADRIENNE — §103§112 Non-Final OA — Pending May 03, 2024
18649533 SYSTEMS AND METHODS FOR MODIFYING DAIRY PROTEIN FUNCTIONALITY BECKER, DREW E 1792 §102§103§112 Non-Final OA — Pending Apr 29, 2024
18705175 TOLL-LIKE RECEPTOR AGONISTS AND ANTAGONISTS AND USES THEREOF ONDACHI, PAULINE WANJIKU MUCH — §103DP Non-Final OA — Pending Apr 26, 2024
18642224 PRECISION FUNCTIONAL MAPPING (PFM) TO PERSONALIZE NEUROMODULATION IN PSYCHIATRIC AND NEUROLOGICAL APPLICATIONS CHNG, JOY POH AI 3686 §101§112 Non-Final OA — Pending Apr 22, 2024
18639608 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF MCDOWELL, BRIAN E 1624 §102§103 Non-Final OA 3d overdue Pending Apr 18, 2024
18635934 ADAPTIVE REAL-TIME STATE SPACE CONTROL OF A NEUROSTIMULATION DEVICE LEE, BRYAN MCALLISTER 3796 §102 Non-Final OA 12d Pending Apr 15, 2024
18633908 THERAPEUTIC COMPOUNDS MILLER, DALE R — §103 Non-Final OA — Pending Apr 12, 2024
18631916 METHODS AND COMPOSITIONS FOR IMPROVING IMMUNOTHERAPY LOGSDON, CHARLES — §103§112 Non-Final OA — Pending Apr 10, 2024
18696252 PARALLEL TRANSMIT RADIO FREQUENCY PULSE DESIGN WITH DEEP LEARNING PATEL, RISHI R 2896 §103 Non-Final OA — Pending Mar 27, 2024
18696138 STENT AND METHOD FOR SECURING AIR FLOW BY RELIEVING STENOSIS OF RESPIRATORY ORGAN HU, ANN M — §102§103 Non-Final OA — Pending Mar 27, 2024
18605241 METHODS OF FORMING AN OXIDE USING VAN DER WAALS MATERIALS TALBOT, BRIAN K 1784 §103§112 Non-Final OA — Pending Mar 14, 2024
18690594 SALMONELLA ENGINEERED FOR NONTOXIC COLONIZATION OF TUMORS STAVROU, CONSTANTINA E 1632 §102§103 Non-Final OA — Pending Mar 08, 2024
18593314 CONJUGATES AND METHODS OF USE THEREOF BOWERS, ERIN M 1653 §102§103 Non-Final OA — Pending Mar 01, 2024
18587203 SUSPENDED PARTICLE CONCENTRATION, DETECTION, AND ANALYSIS SCHNASE, PAUL DANIEL 2877 §103 Final Rejection 35d Pending Feb 26, 2024
18438184 BOTTLEBRUSH POLYMERS AND METHODS THEREOF KASSA, TIGABU 1619 §102§103 Non-Final OA — Pending Feb 09, 2024
18291525 BIOMATERIALS FOR EMBOLIZATION AND DRUG DELIVERY WORSHAM, JESSICA N 1615 §102§112 Non-Final OA — Pending Jan 23, 2024
18579222 SYSTEMS AND METHODS FOR CONTROLLING A MEDICAL DEVICE USING BAYESIAN PREFERENCE MODEL BASED OPTIMIZATION AND VALIDATION BAIG, RUMAISA RASHID 3796 §103§112 Non-Final OA — Pending Jan 12, 2024
18403891 HIGHLY FLUORINATED COMPOUNDS FOR 19F MRI-BASED THERMOMETRY BRAZIN, JACQUELINE — §102§112 Non-Final OA — Pending Jan 04, 2024
18573327 COPOLYMERS AND DEGRADABLE PLASTICS INCLUDING SALICYLATES NGUYEN, HA S — §102§103 Non-Final OA — Pending Dec 21, 2023
18570723 TARGETED ADAM17 BLOCKER COMPOUNDS, ANTI-ADAM17 ANTIBODIES, METHODS OF MAKING, AND METHODS OF USING HUYNH, PHUONG N — §102§103§112 Non-Final OA — Pending Dec 15, 2023
18571000 APPARATUSES, SYSTEMS, AND METHODS FOR FASCIAL CLOSURE DORNBUSCH, DIANNE 3771 §103 Non-Final OA 9d Pending Dec 15, 2023
18540131 BEHAVIORAL FORENSICS IN SOCIAL NETWORKS MINCEY, JERMAINE A — §101§103 Non-Final OA — Pending Dec 14, 2023
18536537 BIO-ENHANCED REMEDIATION AND OIL RECOVERY MODEL SYSTEM AND METHODS KASS, BENJAMIN JOSEPH 1796 §102§103§112 Non-Final OA — Pending Dec 12, 2023
18565831 METHODS OF USING ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T CELLS HAM, JIEUN — §103§112DP Non-Final OA — Pending Nov 30, 2023
18565948 METHODS, DEVICES AND SYSTEMS FOR SEPARATING BIOLOGICAL ANALYTES FROM SAMPLES FISHER, BRITTANY I — §102§103§112 Non-Final OA — Pending Nov 30, 2023
18520008 MAGNETO-PHOTONIC PARTICLES PATEL, RONAK C 1788 §103 Non-Final OA — Pending Nov 27, 2023
18501663 DEVICE FOR TREATMENT OF TRAUMATIC BRAIN INJURY AND RELATED SYSTEMS AND METHODS SIRCAR, ALISHA JITENDRA 3792 §102§103§112 Final Rejection 98d overdue Pending Nov 03, 2023
18286955 Glycan Targets of Serum IgG and IgM Antibodies WEN, SHARON X 1641 §103 Non-Final OA — Pending Oct 13, 2023
18286682 METHODS AND MATERIALS FOR DETECTING MISFOLDED POLYPEPTIDES WHITE, DENNIS MICHAEL 1758 §103 Non-Final OA — Pending Oct 12, 2023
18237360 METALLOENZYME MODULATORS PIHONAK, SARAH 1627 §102§112 Non-Final OA 27d Pending Aug 23, 2023
18277444 ARTIFICIAL DNA REPLISOME AND METHODS OF USE THEREOF FRONDA, CHRISTIAN L 1652 §103§112 Non-Final OA 70d Pending Aug 16, 2023
18228422 SELECTIVE BRD4-DEGRADER MOLECULES BURKETT, DANIEL JOHN 1624 §112 Final Rejection — Pending Jul 31, 2023
18223914 SYSTEMS AND METHODS FOR PREDICTING EXTERNAL RESISTIVE FORCES ENCOUNTERED BY INDUSTRIAL MACHINES DRAPEAU, SIMEON PAUL — §101§102§103 Non-Final OA — Pending Jul 19, 2023
18340592 Cationic Bottlebrush Polymers for Gene Delivery BOYLE, ROBERT C 1635 §102§112 Non-Final OA — Pending Jun 23, 2023
18337578 LOCAL VOLT/VAR CONTROLLERS WITH STABILITY GUARANTEES YOON, ERIC 2118 §103§112 Final Rejection 5d overdue Pending Jun 20, 2023
18207970 MULTI-PROTEIN CLASSIFIER FOR DETECTING EARLY-STAGE OVARIAN CANCER ALABI, OYELEYE A 1797 §101§103 Non-Final OA 56d Pending Jun 09, 2023
18195188 SOLID COMPOUND RAPID REDUCTION SYSTEMS AND METHODS HILL, STEPHANI A 1735 §103 Non-Final OA — Pending May 09, 2023
18141728 MASKED SINGLE-DOMAIN ANTIBODIES AND METHODS THEREOF TAYLOR, LIA ELAN 1641 §112 Final Rejection 19d Pending May 01, 2023
18027576 SHAPE OPTIMIZED PREPARATION AND RESTORATION DEVICES, SYSTEMS, AND METHODS FOR DENTAL AND OTHER APPLICATIONS PATEL, YOGESH P 3772 §102§112 Non-Final OA 33d Pending Mar 21, 2023
18044734 SHAPE MEMORY ALLOY MICROFILAMENT YARNS HUANG, GRACE 3732 §103 Final Rejection 9d Pending Mar 09, 2023
18044482 ENGINEERED IMMUNE CELLS FOR REAGENT DELIVERY BELYAVSKYI, MICHAIL A 1644 §103 Non-Final OA — Pending Mar 08, 2023
18041542 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TREATING AUTOIMMUNITY BELYAVSKYI, MICHAIL A 1644 §102§103DP Final Rejection — Pending Feb 13, 2023
18109039 Cardiopulmonary Resuscitation Catheter and Related Systems and Methods GRAY, PHILLIP A 3783 §102§103 Final Rejection 126d overdue Pending Feb 13, 2023
18012153 REMOVABLE PARTIAL DENTURE TO, HOLLY T 3772 §103 Non-Final OA 146d overdue Pending Dec 21, 2022
18068600 ULTRA-COMPACT, PASSIVE, WIRELESS SENSOR USING QUANTUM CAPACITANCE EFFECT IN GRAPHENE ROLAND, CHRISTOPHER M 2893 DP Final Rejection 7d Pending Dec 20, 2022
18073263 METHOD AND APPARATUS FOR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY NICHOLS, CHARLES W 3783 §103 Non-Final OA 60d overdue Pending Dec 01, 2022
18000258 COPOLYMERS FOR INTRACELLULAR THERAPEUTIC NUCLEIC ACID PAYLOAD DELIVERY SASTRI, SATYA B 1762 §103§112 Non-Final OA 66d overdue Pending Nov 29, 2022
17984720 METHODS, COMPOSITIONS, AND KITS FOR EXPANDING NATURAL KILLER CELLS PRONZATI, GINA 1633 §102§103§112 Non-Final OA — Pending Nov 10, 2022
17996291 MAGNETIC PARTICLE SPECTROSCOPY METHOD AND DEVICE KRCHA, MATTHEW D 1796 §103§112 Non-Final OA — Pending Oct 14, 2022
17953981 NON-FIBRILLAR HEMOGLOBIN S OLIGOMERS AND METHODS TO IDENTIFY MODULATORS OF HEMOGLOBIN S POLYMERIZATION TURK, NEIL N 1798 §101§112 Final Rejection 8d Pending Sep 27, 2022
17945203 IRON NITRIDE POWDER WITH ANISOTROPIC SHAPE POLLOCK, AUSTIN M 1738 §103 Non-Final OA — Pending Sep 15, 2022
17867028 EXERCISE RECOMMENDATION THROUGH PARALLEL COMPUTING ANGELES, JOSE 3715 §101§102§103 Final Rejection — Pending Jul 18, 2022
17849534 System and Method for an Improved Redundant Crossfire Circuit in a Fully Integrated Neurostimulation Device and Its Use in Neurotherapy SPENCER, MAXIMILIAN TOBIAS 3774 §103 Final Rejection — Pending Jun 24, 2022
17843086 PERFUSION SYSTEM FOR CORNEAL ENDOTHELIAL CELL GRAFT EVALUATION BEHARRY, ZANNA MARIA 1632 §103Other Final Rejection 13d Pending Jun 17, 2022
17664339 GASTRIC PLACEMENT CONFIRMATION DEVICE GOLLAMUDI, NEERAJA 3783 §102§103§112 Non-Final OA — Pending May 20, 2022
17748809 PURGE VALVE ASSEMBLIES SYSTEMS AND METHODS FREDRICKSON, COURTNEY B 3783 §102§103 Final Rejection 40d Pending May 19, 2022
17723912 IDENTIFYING NEAR-FALL EVENTS BASED ON INERTIAL MEASUREMENT UNIT DATA PATEL, NIDHI NIRAJ 3791 §101§102§103 Non-Final OA — Pending Apr 19, 2022
17700880 GENETICALLY-EDITED IMMUNE CELLS AND METHODS OF THERAPY SPENCER, ANDREA LYNNE MORRIS 1631 §103§112 Final Rejection — Pending Mar 22, 2022
17762354 NK ENGAGER COMPOUNDS THAT BIND VIRAL ANTIGENS AND METHODS OF USE BENAVIDES, JENNIFER ANN 1675 §103§112DP Non-Final OA 31d overdue Pending Mar 21, 2022
17635111 CHIMERIC ANTIGEN RECEPTORS FOR TREATING MYELOID MALIGNANCIES BERHANE, SELAM 1675 §103§112Other Final Rejection 39d Pending Feb 14, 2022
17595384 SYSTEM AND METHOD FOR CLOSED LOOP CONTROL OF AUTONOMIC FUNCTION ABOUELELA, MAY A 3791 §102§103 Final Rejection — Pending Nov 15, 2021
17429452 GENETICALLY MODIFIED GAMMA DELTA T CELLS AND METHODS OF MAKING AND USING EBBINGHAUS, BRIANA NOEL 1632 §103§112 Non-Final OA 30d Pending Aug 09, 2021
17387503 CHEMICAL SENSORS WITH NON-COVALENT SURFACE MODIFICATION OF GRAPHENE EOM, ROBERT J 1797 §112 Non-Final OA 46d overdue Pending Jul 28, 2021
17248845 ASSISTED LEARNING WITH MODULE PRIVACY RAMESH, TIRUMALE K 2121 §103 Final Rejection — Pending Feb 10, 2021
17262541 PLATFORM FOR DEVELOPING SOIL-BORNE PLANT PATHOGEN INHIBITING MICROBIAL CONSORTIA SABOUR, GHAZAL 1686 §103 Final Rejection — Pending Jan 22, 2021
17147151 METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL POHNERT, STEVEN C 1683 §101§112 Non-Final OA — Pending Jan 12, 2021
15764187 CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS AS THERAPEUTIC INTERVENTIONS FOR AUTO- AND ALLO-IMMUNITY JEAN-LOUIS, SAMIRA JM 1645 §103 Non-Final OA 332d overdue Pending Mar 28, 2018
14775998 CRYOPRESERVATIVE COMPOSTIONS AND METHODS LANDAU, SHARMILA GOLLAMUDI 1653 §103§112 Non-Final OA — Pending Sep 14, 2015

Managing Regents of the University of Minnesota's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month